Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;31(35):5779-5804.
doi: 10.2174/0109298673253678230920054220.

The Mechanisms of miRNAs on Target Regulation and their Recent Advances in Atherosclerosis

Runting Yin  1 , Hongyu Lu  1 , Yixin Cao  2 , Jia Zhang  1 , Geng Liu  1 , Qian Guo  1 , Xinyu Kai  1 , Jiemin Zhao  1 , Yuan Wei  1
Affiliations
Review

The Mechanisms of miRNAs on Target Regulation and their Recent Advances in Atherosclerosis

Runting Yin et al. Curr Med Chem. 2024.

Abstract

miRNAs are crucial regulators in a variety of physiological and pathological processes, while their regulation mechanisms were usually described as negatively regulating gene expression by targeting the 3'-untranslated region(3'-UTR) of target gene miRNAs through seed sequence in tremendous studies. However, recent evidence indicated the existence of non-canonical mechanisms mediated by binding other molecules besides mRNAs. Additionally, accumulating evidence showed that functions of intracellular and intercellular miRNAs exhibited spatiotemporal patterns. Considering that detailed knowledge of the miRNA regulating mechanism is essential for understanding the roles and further clinical applications associated with their dysfunction and dysregulation, which is complicated and not fully clarified. Based on that, we summarized the recently reported regulation mechanisms of miRNAs, including recognitions, patterns of actions, and chemical modifications. And we also highlight the novel findings of miRNAs in atherosclerosis progression researches to provide new insights for non-coding RNA-based therapy in intractable diseases.

Keywords: argonaute; atherosclerosis; methylation modification; miRNA sponge; miRNA target; pri-miRNAs..

PubMed Disclaimer

References

    1. Krol J.; Loedige I.; Filipowicz W.; The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010,11(9),597-610 - DOI - PubMed
    1. O’Brien J.; Hayder H.; Zayed Y.; Peng C.; Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 2018,9,402 - DOI - PubMed
    1. Saliminejad K.; Khorram Khorshid H.R.; Soleymani Fard S.; Ghaffari S.H.; An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 2019,234(5),5451-5465 - DOI - PubMed
    1. Rivera J.; Gangwani L.; Kumar S.; Mitochondria localized microRNAs: An unexplored miRNA niche in Alzheimer’s disease and aging. Cells 2023,12(5),742 - DOI - PubMed
    1. Duarte F.V.; Palmeira C.M.; Rolo A.P.; The emerging role of MitomiRs in the pathophysiology of human disease. Adv Exp Med Biol 2015,888,123-154 - DOI - PubMed